MedPath
HSA Approval

VASOPRESSIN INJECTION USP 20 u/ml

SIN08350P

VASOPRESSIN INJECTION USP 20 u/ml

VASOPRESSIN INJECTION USP 20 u/ml

September 19, 1995

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantFRESENIUS KABI (SINGAPORE) PTE LTD
Licence HolderFRESENIUS KABI (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

SUBCUTANEOUS, INTRAMUSCULAR

Medical Information

H01BA01

vasopressin (argipressin)

Manufacturer Information

FRESENIUS KABI (SINGAPORE) PTE LTD

Fresenius Kabi USA, LLC

Active Ingredients

VASOPRESSIN

20 u/ml

Vasopressin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VASOPRESSIN INJECTION USP 20 u/ml - HSA Approval | MedPath